Toggle navigation
Home
Solutions
By Diseases
Aging
Autoimmune Diseases
Blood Disorders
Anemia
Myelodysplastic Syndromes
Cancer
Colorectal Cancer
Hepatocellular Carcinoma
Pancreatic Ductal Adenocarcinoma (PDAC)
Cardiovascular Disease
Atherosclerosis
Iron Overload Cardiomyopathy
Neurodegenerative Disease
Alzheimer's Disease
Friedreich's Ataxia
Parkinson's Disease
Cutaneous Abnormalities
Psoriasis
Vitiligo
Gastrointestinal Diseases
Inflammatory Bowel Disease (IBD)
Metabolic Disorders
Haemochromatosis
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Porphyria Cutanea Tarda
Type 2 Diabetes
Musculoskeletal Diseases
Restless Legs Syndrome
By Areas
Iron Metabolism-related Research Services
Iron Metabolism-related Gene-based Services
Iron Metabolism-related Cell Services
Iron Metabolism-related Protein Services
Iron Metabolism-related Disease Research Services
Iron Metabolism-related Disease Model Development Services
Cell-based Models Development
Organoid Models Development
Animal Models Development
Iron Metabolism-related Therapeutic Development Services
Small Molecule Drug Development
Cell Therapy Development
Gene Therapy Development
Therapeutic Antibody Development
Therapeutic Peptide Development
Therapeutic Protein Development
Pharmacokinetics
Drug Safety Evaluation
Iron Metabolism-related Nutraceutical Development
By Types
Iron Supplement Development Service
Iron Absorption Enhancers Development Service
Iron Chelators Development Service
Hepcidin Modulators Development Service
Antioxidants Development Service
By Process
Nutraceutical Formulation Development
Nutraceutical Safety Testing Service
Nutraceutical Efficacy Testing Service
Nutraceutical Bioavailability Studies
Nutraceutical Stability Testing Service
Iron Metabolism-related Cosmetics Development
By Types
Anti-Aging Product Development Service
Anti-Inflammatory Skincare Development
Color Cosmetics Development Service
Barrier Repair Skincare Development Service
Sun Care Products Development Service
Scar Repair Product Development Service
By Process
Cosmetic Formulation Development Service
Cosmetic Safety Testing Service
Cosmetic Efficacy Testing Service
Stability Testing for Cosmetics
Microbiology Testing for Cosmetics
Products
Antibodies
Assay Kits
Inhibitors & Activators
Lysates
Proteins
Applications
Resources
About Us
Careers
Contact Us
Products
Services
UAMC-3203
Home
Products
Inhibitors & Activators
UAMC-3203
Products
Antibodies
Assay Kits
Inhibitors & Activators
Lysates
Proteins
Online Inquiry
Name
*
Email
*
Phone
Services & Products Interested
*
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.
SUBMIT
UAMC-3203
Cat. No.
IC23083
CAS. No.
2271358-64-4
Key Features and Details
Category
Inhibitor&Activator
Formula
C25H37N5O2S
Product Size
10 mg
50 mg
200 mg
Customized Size
Online Inquiry
Product Details
Product Name
UAMC-3203
CAS No.
2271358-64-4
Molecular Weight
471.66
Target
Ferroptosis
Formula
C25H37N5O2S
IC50/EC50
IC50: 12 nM (Ferroptosis)
SMILES
O=S(C(C=C1NCC2=CC=CC=C2)=CC=C1NC3CCCCC3)(NCCN4CCNCC4)=O
Product Overview
Description
UAMC-3203 is a potent and selective Ferroptosis inhibitor with an IC50 of 12 nM.
In Vivo
Activity
No toxicity is observed in mice after repeated injections of UAMC-3203 (20 µmol/kg; injected intraperitoneally; daily, over a period of 4 weeks).
Storage & Handling
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping
Room temperature in continental US; may vary elsewhere.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
Simvastatin
JKE-1716
Vildagliptin-d7
PRIMA-1
DL-alpha-Tocopherol-13C3
Acetylcysteine-d3
α-Eleostearic Acid
L-Glutamine-13C5
Pravastatin Sodium
L-Buthionine-(S,R)-sulfoximine